TYP 0.00% 2.3¢ tryptamine therapeutics limited

Ann: Independent Plexaris and Cevaris testing, page-3

  1. 7,481 Posts.
    lightbulb Created with Sketch. 838
    “The testing showed that both Plexaris and Cevaris had different and distinct activities to
    comparison drugs. This confirms our belief that exosomes are a distinct and potentially
    new class of medicine, different from existing medicines,” he adds. “Importantly, neither
    was shown to be cytotoxic, and neither caused antiproliferative effects at the
    concentrations tested.”
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
0.000(0.00%)
Mkt cap ! $25.04M
Open High Low Value Volume
2.3¢ 2.3¢ 2.3¢ $4.189K 182.1K

Buyers (Bids)

No. Vol. Price($)
1 250000 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 13103 1
View Market Depth
Last trade - 15.45pm 17/07/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.